Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
290 GBX | -4,61% | +7,41% | +2,47% |
Attività
Numero di dipendenti: 1 988
Vendite per attività
HKD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Oncology/Immunology - Research and Development
43,5
%
| 307 | 9,2 % | 2 853 | 43,5 % | +829,49% |
Other Ventures
36,9
%
| 2 056 | 61,6 % | 2 422 | 36,9 % | +17,81% |
Oncology/Immunology - Marketed Products
19,6
%
| 976 | 29,2 % | 1 285 | 19,6 % | +31,68% |
Vendite per regione
HKD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
China
57,9
%
| 3 339 | 100,0 % | 3 796 | 57,9 % | +13,69% |
United States and Others
42,1
%
| 0 | 0,0 % | 2 764 | 42,1 % | - |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Wei Guo Su
CEO | Chief Executive Officer | 66 | 01/01/05 |
Chig Fung Cheng
DFI | Director of Finance/CFO | 57 | 01/07/08 |
Michael Shi
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/01/22 |
Karen Atkin
COO | Chief Operating Officer | 58 | 01/01/21 |
Edith Shih
BRD | Director/Board Member | 71 | 01/01/00 |
Mark Lee
IRO | Public Communications Contact | 46 | - |
Selina Zhang
HRO | Human Resources Officer | - | 01/03/22 |
Yiling Cui
LAW | General Counsel | - | - |
Charles Nixon
LAW | General Counsel | 54 | 01/01/06 |
May Wang
PRN | Corporate Officer/Principal | 60 | 01/01/10 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Chi Keung To
CHM | Chairman | 72 | 01/01/00 |
Graeme Jack
BRD | Director/Board Member | 73 | 01/03/17 |
Dan Eldar
BRD | Director/Board Member | 70 | 01/08/16 |
Edith Shih
BRD | Director/Board Member | 71 | 01/01/00 |
Paul Carter
BRD | Director/Board Member | 63 | 01/02/17 |
Chig Fung Cheng
DFI | Director of Finance/CFO | 57 | 01/07/08 |
Wei Guo Su
CEO | Chief Executive Officer | 66 | 01/01/05 |
Ling Yang
BRD | Director/Board Member | 44 | 13/07/23 |
Shu Kam Mok
BRD | Director/Board Member | 63 | 01/01/17 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 871 256 270 | 456 289 920 ( 52,37 %) | 0 | 52,37 % |
Coordinate società
HUTCHMED (China) Ltd.
Cheung Kong Center 2 Queen's Road Central
, Hong Kong
+852 2121 8200
http://www.hutch-med.comSettore
Vendite per attività
Vendite per regione
Revisioni EPS
Fatturato trimestrale - Indice di sorpresa
Variaz. 1 gen. | Capi. | |
---|---|---|
+2,47% | 3,08 Mrd | |
+25,83% | 661 Mrd | |
+27,00% | 566 Mrd | |
-6,76% | 352 Mrd | |
+20,34% | 332 Mrd | |
+3,00% | 283 Mrd | |
+13,09% | 231 Mrd | |
+5,46% | 200 Mrd | |
-9,61% | 195 Mrd | |
-6,26% | 145 Mrd |
- Borsa valori
- Azioni
- Azione HCM
- Società HUTCHMED (China) Limited